This leaflet contains a concise overview of the project’s concept and objectives; the presentation of two clinical trials conducted within the project; and highlights the various outputs we will offer to patients...

HAP2 kick-off meeting

13/01/20 - 14/01/20

All partners attended the 2-day meeting, filled with enthusiasm and collaboration as we planned the first year of the project. Over 2020, we’ll be focused on planning for our two clinical trials:...

News & Events

100th patient enrolled in the PREV-HAP study

New publication: Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia

First patient included in the PREV-HAP study!

First Site Initiation Visit completed for the PREV-HAP study

Jean Valade prize awarded to Pr. Antoine Roquilly

New HAP2 status meeting

1st HAP2 paper published!

Wedata’s avatars solution certified by the French Data Protection Authority

PREV-HAP investigators’ meeting

Clinical study “PREV-HAP” submitted for approval

HAP2 leaflet now available

HAP2 kick-off meeting